EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Is breathing frequency a potential means for monitoring exercise intensity in people with atrial fibrillation and coronary heart disease when heart rate is mitigated?

John P Buckley, Tasuku Terada, Anna Lion, Jennifer L Reed

European Journal of Applied Physiology · 2024

DOI: 10.1007/s00421-024-05487-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Applied Physiology, 2024. Verfasst von John P Buckley und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Allied Health Professions, Keele University, Staffordshire, ST5 5BG, UK. j.p.buckley@keele.ac.uk. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Rate, Coronary Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Moderate-intensity aerobic exercise is safe and beneficial in atrial fibrillation (AF) and coronary heart disease (CHD). Irregular or rapid heart rates (HR) in AF and other heart conditions create a challenge to using HR to monitor exercise intensity. The purpose of this study was to assess the potential of breathing frequency (BF) to monitor exercise intensity in people with AF and CHD without AF.

Methods

This observational study included 30 AF participants (19 Male, 70.7 ± 8.7 yrs) and 67 non-AF CHD participants (38 Male, 56.9 ± 11.4 yrs). All performed an incremental maximal exercise test with pulmonary gas exchange.

Results

Peak aerobic power in AF ( $${\dot{\text{V}}}$$ V ˙ O 2 peak; 17.8 ± 5.0 ml.kg −1 .min −1 ) was lower than in CHD (26.7 ml.kg −1 .min −1 ) ( p < .001). BF responses in AF and CHD were similar (BF peak: AF 34.6 ± 5.4 and CHD 36.5 ± 5.0 breaths.min −1 ; p = .106); at the 1st ventilatory threshold (BF@VT-1: AF 23.2 ± 4.6; CHD 22.4 ± 4.6 breaths.min −1 ; p = .240). % $${\dot{\text{V}}}$$ V ˙ O 2 peak at VT-1 were similar in AF and CHD (AF: 59%; CHD: 57%; p = .656).

Conclusion

With the use of wearable technologies on the rise, that now include BF, this first study provides an encouraging potential for BF to be used in AF and CHD. As the supporting data are based on incremental ramp protocol results, further research is required to assess BF validity to manage exercise intensity during longer bouts of exercise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart RateCoronary DiseaseHumansMaleFemaleMiddle AgedAgedExerciseRespiratory RateExercise TestOxygen ConsumptionMonitoring, Physiologic

Stichwörter der Autor:innen

Anaerobic thresholdBreathing rateCardiac rehabilitationHeart rate

Autor:innen und Institutionen

  • School of Allied Health Professions, Keele University, Staffordshire, ST5 5BG, UK. j.p.buckley@keele.ac.uk.
  • University of Ottawa Heart Institute, Ottawa, ON, Canada.
  • Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
  • Rehabilitation Technologies Network+, Faculty of Engineering, University of Nottingham, Nottingham, UK.
  • School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Zitieren

APA

Buckley, J. P., Terada, T., Lion, A., & Reed, J. L. (2024). Is breathing frequency a potential means for monitoring exercise intensity in people with atrial fibrillation and coronary heart disease when heart rate is mitigated?. European Journal of Applied Physiology. https://doi.org/10.1007/s00421-024-05487-2

Vancouver

Buckley JP, Terada T, Lion A, Reed JL. Is breathing frequency a potential means for monitoring exercise intensity in people with atrial fibrillation and coronary heart disease when heart rate is mitigated?. European Journal of Applied Physiology. 2024. doi:10.1007/s00421-024-05487-2

BibTeX
@article{Buckley2024,
  author = {Buckley, John P and Terada, Tasuku and Lion, Anna and Reed, Jennifer L},
  title = {Is breathing frequency a potential means for monitoring exercise intensity in people with atrial fibrillation and coronary heart disease when heart rate is mitigated?},
  journal = {European Journal of Applied Physiology},
  year = {2024},
  doi = {10.1007/s00421-024-05487-2}
}
Kostenlos starten →